Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:1890-1895
Published online before print September 27, 2004, doi: 10.1161/01.CIR.0000143629.55725.D9
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/14/1890    most recent
01.CIR.0000143629.55725.D9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hemmelgarn, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hemmelgarn, B. R.
Related Collections
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow CV surgery: coronary artery disease
Right arrow Epidemiology
Right arrowRelated Article

(Circulation. 2004;110:1890-1895.)
© 2004 American Heart Association, Inc.


Cardiovascular Surgery

Survival After Coronary Revascularization Among Patients With Kidney Disease

Brenda R. Hemmelgarn, PhD, MD; Danielle Southern, MSc; Bruce F. Culleton, MD; L. Brent Mitchell, MD; Merril L. Knudtson, MD; William A. Ghali, MD, MPH, for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators*

From the Departments of Medicine (B.R.H., B.F.C., L.B.M., M.L.K., W.A.G.) and Community Health Sciences (B.R.H., W.A.G.) and the Centre for Health and Policy Studies (D.S., W.A.G.), University of Calgary, Calgary, Alberta, Canada.

Correspondence to Dr Brenda Hemmelgarn, Division of Nephrology, Foothills Medical Center, 1403 29th St NW, Calgary, Alberta T2N 2T9, Canada. E-mail brenda.hemmelgarn{at}calgaryhealthregion.ca

Received May 27, 2004; revision received July 21, 2004; accepted August 2, 2004.

Background— The optimal approach to revascularization in patients with kidney disease has not been determined. We studied survival by treatment group (CABG, percutaneous coronary intervention [PCI], or no revascularization) for patients with 3 categories of kidney function: dialysis-dependent kidney disease, non–dialysis-dependent kidney disease, and a reference group (serum creatinine <2.3 mg/dL).

Methods and Results— Data were derived from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH), which captures information on all patients undergoing cardiac catheterization in Alberta, Canada. Characteristics and patient survival in 662 dialysis patients (1.6%) and 750 non–dialysis-dependent kidney disease patients (1.8%) were compared with the remainder of the 40 374 patients (96.6%). For the reference group, the adjusted 8-year survival rates for CABG, PCI, and no revascularization (NR) were 85.5%, 80.4%, and 72.3%, respectively (P<0.001 for CABG versus NR; P<0.001 for PCI versus NR). Adjusted survival rates were 45.9% for CABG, 32.7% for PCI, and 29.7% for NR in the nondialysis kidney disease group (P<0.001 for CABG versus NR; P=0.48 for PCI versus NR) and 44.8% for CABG, 41.2% for PCI, and 30.4% for NR in the dialysis group (P=0.003 for CABG versus NR; P=0.03 for PCI versus NR).

Conclusions— Compared with no revascularization, CABG was associated with better survival in all categories of kidney function. PCI was also associated with a lower risk of death than no revascularization in reference patients and dialysis-dependent kidney disease patients but not in patients with non–dialysis-dependent kidney disease. The presence of kidney disease or dependence on dialysis should not be a deterrent to revascularization, particularly with CABG.


Key Words: revascularization • coronary disease • kidney • epidemiology


Related Article:


Circulation 2004 110: 1875. [Extract] [Full Text]



This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. H.M. van Straten, M. A. Soliman Hamad, A. A.J. van Zundert, E. J. Martens, J. P.A.M. Schonberger, and A. M. de Wolf
Preoperative renal function as a predictor of survival after coronary artery bypass grafting: Comparison with a matched general population
J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 971 - 976.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc IntervHome page
C. E. Appleby, J. Ivanov, S. Lavi, K. Mackie, E. M. Horlick, D. Ing, C. B. Overgaard, P. H. Seidelin, R. von Harsdorf, and V. Dzavik
The Adverse Long-Term Impact of Renal Impairment in Patients Undergoing Percutaneous Coronary Intervention in the Drug-Eluting Stent Era
Circ Cardiovasc Interv, August 1, 2009; 2(4): 309 - 316.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. K. de Bie, B. van Dam, A. Gaasbeek, M. van Buren, L. van Erven, J. J. Bax, M. J. Schalij, T. J. Rabelink, and J. W. Jukema
The current status of interventions aiming at reducing sudden cardiac death in dialysis patients
Eur. Heart J., July 1, 2009; 30(13): 1559 - 1564.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. G. Hage, R. Venkataraman, G. J. Zoghbi, G. J. Perry, A. M. DeMattos, and A. E. Iskandrian
The scope of coronary heart disease in patients with chronic kidney disease.
J. Am. Coll. Cardiol., June 9, 2009; 53(23): 2129 - 2140.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. H. Lopes, F. da Silva Paulitsch, A. Pereira, C. L. Garzillo, J. F. Ferreira, N. Stolf, and W. Hueb
Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease.
J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1443 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
B. F. Buxton, P. A.R. Hayward, A. E. Newcomb, S. Moten, S. Seevanayagam, and I. Gordon
Choice of conduits for coronary artery bypass grafting: craft or science?
Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 658 - 670.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
I. F. Nevis, A. Mathew, R. J. Novick, C. R. Parikh, P. J. Devereaux, M. K. Natarajan, A. V. Iansavichus, M. S. Cuerden, and A. X. Garg
Optimal Method of Coronary Revascularization in Patients Receiving Dialysis: Systematic Review
Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 369 - 378.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
C. Medi, G. Montalescot, A. Budaj, K. A.A. Fox, J. Lopez-Sendon, G. FitzGerald, D. B. Brieger, and on behalf of the GRACE Investigators
Reperfusion in Patients With Renal Dysfunction After Presentation With ST-Segment Elevation or Left Bundle Branch Block: GRACE (Global Registry of Acute Coronary Events)
J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
C. W. Hamm, H. Möllmann, J.-P. Bassand, and F. van de Werf
CHAPTER 16 Acute Coronary Syndromes
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. H. Mehta, G. E. Hafley, C. M. Gibson, R. A. Harrington, E. D. Peterson, M. J. Mack, N. T. Kouchoukos, R. M. Califf, T. B. Ferguson Jr., J. H. Alexander, et al.
Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery.
J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1149 - 1155.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. B. Chonchol, V. Aboyans, P. Lacroix, G. Smits, T. Berl, and M. Laskar
Long-term outcomes after coronary artery bypass grafting: Preoperative kidney function is prognostic
J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 683 - 689.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, J.-P. Bassand, C. W. Hamm, D. Ardissino, E. Boersma, A. Budaj, F. Fernandez-Aviles, K. A.A. Fox, D. Hasdai, E. M. Ohman, et al.
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Eur. Heart J., July 1, 2007; 28(13): 1598 - 1660.
[Full Text] [PDF]


Home page
QJMHome page
N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend
The treatment of coronary artery disease in patients with chronic kidney disease
QJM, November 1, 2006; 99(11): 723 - 736.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. G. Kutner, R. Zhang, Y. Huang, and C. A. Herzog
Cardiac Rehabilitation and Survival of Dialysis Patients after Coronary Bypass
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1175 - 1180.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. A. Cooper, S. M. O'Brien, V. H. Thourani, R. A. Guyton, C. R. Bridges, L. A. Szczech, R. Petersen, and E. D. Peterson
Impact of Renal Dysfunction on Outcomes of Coronary Artery Bypass Surgery: Results From the Society of Thoracic Surgeons National Adult Cardiac Database
Circulation, February 28, 2006; 113(8): 1063 - 1070.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Zakeri, N. Freemantle, V. Barnett, G. W. Lipkin, R. S. Bonser, T. R. Graham, S. J. Rooney, I. C. Wilson, R. Cramb, B. E. Keogh, et al.
Relation Between Mild Renal Dysfunction and Outcomes After Coronary Artery Bypass Grafting
Circulation, August 30, 2005; 112(9_suppl): I-270 - I-275.
[Abstract] [Full Text] [PDF]